CoreAge Rx vs Super Healthy Rx
Two GLP-1 providers, one scoreboard. We put CoreAge Rx and Super Healthy Rx head-to-head on the published Brief Score — the same six factors, scored the same way.
CoreAge Rx
Super Healthy Rx
The verdict
CoreAge Rx takes this head-to-head.
CoreAge Rx scores 94 to 61 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.
That doesn't make Super Healthy Rx a bad call — it's best for people comparing compounded refill plans who confirm the full selected payment, early-exit rate and consultation-fee treatment in writing. Weigh the six factors below against your own priorities before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.
Factor by factor
Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.
Price, coverage & the tracker
| Compare | CoreAge Rx | Super Healthy Rx |
|---|---|---|
| Brief Score | 94/100 (A) | 61/100 (C) |
| Semaglutide | From $79/mo Annual offer: 12 months paid upfront, from $948. Main site: from $99/mo; confirm the selected offer. Full price detailsFrom $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo | From $79/mo; full order unconfirmed Compounded injection; selected quantity and full payment need confirmation. One-time purchases; six/twelve-month plans ship quarterly and early exit reprices shipped medication at the three-month rate. Full-ineligibility refund conflicts with nonrefundable $50–$100 consultation fee. Approval plus pharmacy transfer ends cancellation; separate 30-day active-order rule can apply even without shipment. Full price detailsCompounded semaglutide weekly injection offered; complete selected-plan quote unknown; from $79/month advertised, actual selected supply and full payment unconfirmed, one-time purchase and multi-month refill options |
| Tirzepatide | From $129/mo Annual offer: 12 months paid upfront, from $1,548. Main site: from $149/mo; confirm the selected offer. Full price detailsFrom $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo | From $129/mo; full order unconfirmed Compounded injection; selected quantity and full payment need confirmation. One-time purchases; six/twelve-month plans ship quarterly and early exit reprices shipped medication at the three-month rate. Full-ineligibility refund conflicts with nonrefundable $50–$100 consultation fee. Approval plus pharmacy transfer ends cancellation; separate 30-day active-order rule can apply even without shipment. Full price detailsCompounded tirzepatide weekly injection offered; complete selected-plan quote unknown; from $129/month advertised, actual selected supply and full payment unconfirmed, one-time purchase and multi-month refill options |
| Coverage | US only; restrictions by state, confirmed at intake | Multiple U.S. states advertised, with live consultation required in some states; exact patient-state and pharmacy eligibility need confirmation |
| Brand-name access | Not confirmed | The reviewed current GLP-1 offer is compounded; a named branded GLP-1 prescription was not established. |
| Oral / sublingual | Injection only | Unconfirmed |
| On the tracker | Stableprice stable | Newnew to the tracker, no prior reading |
CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.
Super Healthy Rx: From $79 semaglutide/$129 tirzepatide; complete order quote unconfirmed. One-time plans; six/twelve-month early exits reprice shipped supply. Full-ineligibility refund conflicts with $50–$100 nonrefundable consult fee; 30-day finalization applies.
Keep comparing
Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.